Title of article :
SAR studies of 6-(arylamino)-4,4-disubstituted-1-methyl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones as progesterone receptor antagonists
Author/Authors :
Jeffrey C. Kern، نويسنده , , Eugene A. Terefenko، نويسنده , , Andrew Fensome، نويسنده , , Ray Unwallla، نويسنده , , Jay Wrobel، نويسنده , , Yuan Zhu، نويسنده , , Jeffrey Cohen، نويسنده , , Richard Winneker، نويسنده , , Zhiming Zhang، نويسنده , , Puwen Zhang، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2007
Abstract :
We previously disclosed that 6-aryl benzoxazin-2-ones were PR modulators. In a continuation of this work we examined the SAR of new 6-arylamino benzoxazinones and found the targets 1–25, with an extra amino linker between the pendent 6-aryl groups and benzoxazinone or benzoxazine-2-thione core, were PR antagonists. A series of compounds with substituents at the 1- and 4-positions as well as different 6-aryl groups were prepared and tested in the T47D cell alkaline phosphatase assay. Interestingly, the SAR unveiled from the 6-arylamino benzoxazinones was quite different from those of their parent compounds. For example, in contrast to the 6-aryl benzoxazinones, methyl substitution at the 1-position significantly increased the potency of 6-arylamino benzoxazinones. Several 6-arylamino benzoxazinones (e.g., 12, IC50 = 5.0 nM) had low nanomolar in vitro potency as PR antagonists in the T47D cell alkaline phosphatase assay.
Keywords :
Non-steroidal PR modulator , PR antagonists , Progesterone receptor (PR)
Journal title :
Bioorganic & Medicinal Chemistry Letters
Journal title :
Bioorganic & Medicinal Chemistry Letters